ORAMED PHARMACEUTICALS INC

NASDAQ: ORMP (Oramed Pharmaceuticals Inc.)

Last update: 10 Nov, 2024, 7:11PM

2.31

-0.07 (-2.94%)

Previous Close 2.38
Open 2.36
Volume 77,206
Avg. Volume (3M) 96,907
Market Cap 94,176,384
Price / Earnings (TTM) 4.53
Price / Sales 152.49
Price / Book 0.620
52 Weeks Range
1.87 (-19%) — 3.67 (58%)
Earnings Date 7 Nov 2024
Diluted EPS (TTM) 0.110
Total Debt/Equity (MRQ) 0.28%
Current Ratio (MRQ) 27.08
Operating Cash Flow (TTM) -7.92 M
Levered Free Cash Flow (TTM) -2.41 M
Return on Assets (TTM) -4.12%
Return on Equity (TTM) 2.89%

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Mixed Mixed
Biotechnology (Global) Mixed Mixed
Stock Oramed Pharmaceuticals Inc. Mixed Mixed

AIStockmoo Score

-0.8
Analyst Consensus NA
Insider Activity NA
Price Volatility -2.0
Technical Moving Averages 0.0
Technical Oscillators -0.5
Average -0.83

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
ORMP 94 M - 4.53 0.620
ARWR 2 B - - 13.17
REPL 932 M - - 2.24
ADPT 928 M - - 4.03
CGEM 700 M - - 1.19
ABUS 620 M - - 5.64

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

Sector Healthcare
Industry Biotechnology
Investment Style Small Value
% Held by Insiders 10.62%
% Held by Institutions 17.52%

No data within this time range.

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria